SCHEMBL22693059

SCHEMBL22693059

Cc1nc(C(C)(C)C)nc2[nH]ncc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SGK1 O00141 6/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ PLK4 O00444 1/20 0.34
▸ PAK4 O96013 1/20 0.34
▸ ADORA3 P0DMS8 1/20 0.34
▸ PDPK1 O15530 1/20 0.33
▸ ACHE P22303 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ CHEK1 O14757 1/20 0.33
▸ AURKA O14965 1/20 0.33
▸ RET P07949 1/20 0.32
▸ PI4KA P42356 1/20 0.32
▸ XDH P47989 1/20 0.32
▸ LRRK2 Q5S007 1/20 0.32
▸ PI4K2B Q8TCG2 1/20 0.32
▸ PI4K2A Q9BTU6 1/20 0.32
▸ PI4KB Q9UBF8 1/20 0.32
▸ NPC1 O15118 1/20 0.32
▸ RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10139169 0.81 ALDH1A1 (0.34) SMN1; SMN2ALDH1A1PLK4PAK4ADORA3
SCHEMBL18701485 0.80 SMN1; SMN2 (0.36) SMN1; SMN2ALDH1A1PDPK1HTTCHEK1
SCHEMBL13660393 0.77 SMN1; SMN2 (0.38) SMN1; SMN2ALDH1A1ADORA3PDPK1HTT
SCHEMBL26780067 0.77 ALDH1A1 (0.38) SMN1; SMN2ALDH1A1ADORA3PDPK1HTT
SCHEMBL7888421 0.76 CHEK1 (0.40) SGK1SMN1; SMN2ALDH1A1PLK4PAK4
SCHEMBL22402413 0.74 NUDT1 (0.36) SGK1SMN1; SMN2ALDH1A1ADORA3HTT
SCHEMBL14570604 0.73 ADORA2A (0.47) SGK1SMN1; SMN2ALDH1A1PLK4PAK4
SCHEMBL61883 0.73 PLK4 (0.53) SGK1SMN1; SMN2ALDH1A1PLK4PAK4
SCHEMBL24224514 0.72 ALDH1A1 (0.41) SMN1; SMN2ALDH1A1ADORA3HTT
SCHEMBL23186713 0.71 PDPK1 (0.32) ALDH1A1PDPK1CHEK1AURKARET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022002118-A1 FUSED-RING HETEROCYCLE DERIVATIVE AND MEDICAL USE THEREOF 四川海思科制药有限公司 2022-01-06 — — WO disclosed
US-10844049-B2 GLP-1R agonists and uses thereof QILU REGOR THERAPEUTICS INC. (CN) 2020-11-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10844049-B2 GLP-1R agonists and uses thereof GLP1R, GPR119, GIPR SGK1 2110/4885SMN1; SMN2 3477/4885ALDH1A1 564/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback